
Enfamil is owned by Reckitt (LSE: RKT), the British consumer health and hygiene company, through its Mead Johnson Nutrition subsidiary. Reckitt acquired Mead Johnson Nutrition for approximately $16.6 billion in 2017. Enfamil was introduced by Mead Johnson in 1959 and holds approximately 35% of the US infant formula market, making it the second-largest brand alongside Abbott's Similac.
| Brand | Parent Company | Ownership Type |
|---|---|---|
| Enfamil | Reckitt | Wholly owned |
Mead Johnson was founded in 1905 by Edward Mead Johnson in Evansville, Indiana. Edward Mead Johnson had previously co-founded Johnson & Johnson with his brother Robert Wood Johnson in 1886. After leaving Johnson & Johnson, Edward Mead Johnson established Mead Johnson to produce nutritional products, inspired by his son's digestive health issues. The company's first product was a children's laxative, but it soon expanded into infant nutrition.
Enfamil was introduced by Mead Johnson in 1959. The name is derived from "infant formula." The product was developed to closely approximate the nutritional composition of breast milk, using scientific research to achieve the appropriate balance of protein, fat, carbohydrates, vitamins, and minerals. Enfamil quickly became one of the leading infant formula brands in the United States, competing with Abbott's Similac (introduced in 1928).
Mead Johnson was acquired by Bristol-Myers Squibb in 1967 and operated as a subsidiary for over four decades. During this period, Enfamil expanded internationally and introduced specialized formulations including Enfamil Gentlease (for fussiness and gas), Enfamil Nutramigen (for cow's milk protein allergy), and Enfamil Premature (for preterm infants).
In 2009, Bristol-Myers Squibb spun off Mead Johnson Nutrition as an independent publicly traded company on the New York Stock Exchange under ticker MJN. The spin-off allowed Mead Johnson to focus exclusively on infant and child nutrition. As an independent company, Mead Johnson expanded its presence in emerging markets, particularly in China, where demand for imported infant formula was high following the 2008 melamine contamination scandal.
Reckitt acquired Mead Johnson in June 2017 for approximately $16.6 billion, paying $90 per share. The acquisition was intended to boost Reckitt's presence in emerging markets and diversify its product portfolio. However, the integration faced challenges, and the infant formula business underperformed relative to Reckitt's expectations.
During the 2022 US infant formula shortage, caused primarily by the recall and closure of Abbott's Similac manufacturing facility in Sturgis, Michigan, Enfamil benefited from significantly increased demand. Consumers switched from Similac to Enfamil and other brands, and Reckitt expanded production to meet the surge. Reckitt's US infant formula market share increased during the shortage period. However, some of these share gains were reversed as Abbott resumed production and store-brand formulas gained market share.
In 2025, Reckitt announced the strategic review of Mead Johnson, signaling that the infant formula business may not remain part of Reckitt's long-term portfolio.
Is Reckitt the same as Reckitt Benckiser?
Yes. Reckitt is the current trading name of Reckitt Benckiser Group plc. The company rebranded from RB to Reckitt in March 2021 under then-CEO Laxman Narasimhan. The legal name remains Reckitt Benckiser Group plc, and the stock ticker on the London Stock Exchange remains RKT. The rebrand was intended to simplify the corporate identity and align it with the company's purpose in health, hygiene, and nutrition.
What brands does Reckitt own?
Reckitt owns 11 Powerbrands across health, hygiene, and nutrition. Hygiene brands include Dettol, Lysol, Harpic, Vanish, Finish, and Air Wick. Health brands include Mucinex, Nurofen, Strepsils, Gaviscon, and Durex. Nutrition brands include Enfamil and Nutramigen. These brands generated £14.2 billion in net revenue in FY2025 and are sold in over 200 countries. The company divested its Essential Home business in December 2025 for £2.172 billion.
Is Reckitt publicly traded?
Yes, Reckitt Benckiser Group plc is listed on the London Stock Exchange under ticker RKT and is a constituent of the FTSE 100 Index. The company has been publicly traded since the merger of Reckitt and Colman and Benckiser NV in 1999. Major institutional shareholders include Vanguard Group, BlackRock, and State Street Global Advisors. No single shareholder holds a controlling stake.
Who is the CEO of Reckitt?
Kris Licht is the CEO of Reckitt. He was appointed CEO Designate in May 2023 and assumed the role in October 2023. Licht joined Reckitt in 2019 as President of the Health business and previously held senior roles at PepsiCo. Under his leadership, Reckitt has simplified its operating model, launched the Fuel for Growth cost reduction program, and divested the Essential Home business to focus on its core Powerbrands.
Where is Reckitt headquartered?
Reckitt is headquartered in Slough, England, United Kingdom. The company maintains major operations centers in the United States, China, India, and other key markets. Its manufacturing facilities are located across six countries, including the United Kingdom, United States, China, India, Mexico, and Thailand.
How many people work for Reckitt?
Reckitt employs approximately 40,000 people worldwide across its manufacturing facilities, research centers, and commercial offices. The company has a significant presence in North America, Europe, and Asia-Pacific regions.
What is Reckitt's revenue?
Reckitt reported net revenue of £14.2 billion for FY2025, with adjusted operating profit of £3.5 billion and adjusted operating margin of 24.9%. Core Reckitt like-for-like growth was 5.2%, driven by Emerging Markets growth of 14.6%. The company returned £2.3 billion to shareholders through buybacks and dividends, plus a special dividend of approximately £1.6 billion in February 2026.
What are Reckitt's largest brands?
Dettol and Lysol are the largest brands by revenue, driven by their global disinfection franchise. Mucinex is the largest health brand, driven by its US cough and cold market position. Enfamil is the largest nutrition brand, with approximately 35% US infant formula market share. Durex is the world's most widely distributed sexual wellness brand. Finish is the global leader in automatic dishwasher detergent by volume.
Enfamil has faced several notable issues:
2022 Formula Shortage: While the shortage was caused by Abbott's recall, Enfamil and Reckitt faced pressure to increase production rapidly. Reckitt was praised for scaling production during the crisis but also faced criticism for pricing during the shortage period.
FDA Inspection Findings: In 2022 and 2023, the FDA conducted increased inspections of infant formula manufacturing facilities. Reckitt's facilities received some observations for improvement, though no major safety violations were found and no Enfamil products were recalled.
Marketing Practices: Enfamil, like other infant formula brands, has faced criticism from public health advocates regarding marketing practices that may discourage breastfeeding. The International Code of Marketing of Breast-milk Substitutes, adopted by the World Health Organization, restricts marketing of infant formula. Compliance with this code varies by country and has been a source of ongoing debate.
Product Liability Lawsuits: Enfamil has been the subject of product liability lawsuits, including cases alleging that cow's milk-based formula contributed to necrotizing enterocolitis (NEC) in premature infants. Similar lawsuits have been filed against Abbott (Similac). These cases are ongoing and have led to increased scrutiny of formula for premature infants.
Reckitt Strategic Review: The 2025 announcement of a strategic review of Mead Johnson has created uncertainty about Enfamil's future ownership and investment priorities.
These competing brands operate in the same categories and provide similar products or services. Compare key attributes to understand market positioning and competitive landscape.
| Brand | Parent Company | Country | Founded | Market Position | Primary Market | Gender Target |
|---|---|---|---|---|---|---|
| Abbott Laboratories | USA | 1925 | Us infant-formula-leader | United states | All-consumers |
Market Positioning: Enfamil competes with 1 brands in the same categories, ranging from mass market to luxury positioning.
Geographic Distribution: Competitors are headquartered across multiple regions, indicating global competition in this market segment.
Brand Heritage: Competitor brands range from established heritage brands to newer market entrants, with founding years spanning several decades.
Looking for brands with different ownership structures? These similar brands are not owned by Reckitt, giving you alternative choices that support different corporate structures.
Baby CareOwned by Abbott Laboratories
American infant formula brand owned by Abbott Laboratories, introduced in 1925 and the largest infant formula brand in the United States. Similac faced a major product recall in 2022 that contributed to a national infant formula shortage.
Similac is owned by Abbott Laboratories, offering a different ownership alternative.
Baby CareOwned by The Honest Company, Inc.
Consumer goods brand co-founded by Jessica Alba in 2012, focused on non-toxic household and baby products, publicly traded on NASDAQ under ticker HNST.
The Honest Company operates independently without a large parent corporation.
Baby CareOwned by Evyap
Turkish brand of baby care and gentle personal care products manufactured by Evyap, formulated for sensitive infant skin. Sold in over 100 countries across Europe, Asia, the Middle East, and Africa.
Evy Baby is owned by Evyap, a private company, a different structure than Enfamil's parent.
Baby CareOwned by Procter & Gamble Company
Baby laundry detergent brand owned by Procter and Gamble. The
Dreft is owned by Procter & Gamble Company, offering a different ownership alternative.
Baby CareOwned by Kenvue
Baby care brand owned by Kenvue, offering gentle shampoo, lotion, and powder for infants worldwide since 1893.
Johnson's Baby is owned by Kenvue, offering a different ownership alternative.
Baby CareOwned by Newell Brands Inc.
German baby care brand founded in 1956, specializing in baby bottles, pacifiers, and infant feeding products. Owned by Newell Brands (NASDAQ: NWL) since 2011. Known for orthodontic pacifier designs developed with input from dental professionals. Faced a microplastics class action lawsuit in 2024.
NUK is owned by Newell Brands Inc., offering a different ownership alternative.
Discover popular brands and companies in the Baby Care category and related searches from other users.

American brand of premium jogging strollers and baby gear, founded in 1984 by Phil Baechler and owned by Newell Brands (NASDAQ: NWL), sold in over 60 countries worldwide.

Baby laundry detergent brand owned by Procter and Gamble. The

Turkish brand of baby care and gentle personal care products manufactured by Evyap, formulated for sensitive infant skin. Sold in over 100 countries across Europe, Asia, the Middle East, and Africa.